Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Association of traits of metabolic syndrome with glucose abnormalities.

Hoffmann IS, Cubeddu LX.

Am J Ther. 2013 Jul-Aug;20(4):363-8. doi: 10.1097/MJT.0b013e318235f2b8.

PMID:
23591026
2.

Prevalence of glucose abnormalities and diagnostic value of fasting glucose and fasting insulin in urban Hispanics.

Hoffmann IS, Alfieri AB, Cubeddu LX.

Am J Ther. 2013 Jul-Aug;20(4):369-75. doi: 10.1097/MJT.0b013e318235f2f5.

PMID:
23528370
3.

Impact of traits of metabolic syndrome on β-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects.

Cubeddu LX, Hoffmann IS.

Metab Syndr Relat Disord. 2012 Oct;10(5):344-50. Epub 2012 Jul 17.

PMID:
22803772
4.

Metabolic syndrome: an all or none or a continuum load of risk?

Cubeddu LX, Hoffmann IS.

Metab Syndr Relat Disord. 2012 Feb;10(1):14-9. doi: 10.1089/met.2011.0058. Epub 2011 Oct 27.

PMID:
22032809
5.
6.

Salt and the metabolic syndrome.

Hoffmann IS, Cubeddu LX.

Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):123-8. doi: 10.1016/j.numecd.2008.02.011. Epub 2008 Jun 16.

PMID:
18556187
7.
8.
9.

Effects of lifestyle changes and metformin on salt sensitivity and nitric oxide metabolism in obese salt-sensitive Hispanics.

Hoffmann IS, Alfieri AB, Cubeddu LX.

J Hum Hypertens. 2007 Jul;21(7):571-8. Epub 2007 Apr 26.

PMID:
17460713
10.

Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome.

Hoffmann IS, Cubeddu LX.

J Hum Hypertens. 2007 Jun;21(6):438-44. Epub 2007 Feb 1.

PMID:
17273153
11.

NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics.

Castejon AM, Bracero J, Hoffmann IS, Alfieri AB, Cubeddu LX.

J Hum Hypertens. 2006 Oct;20(10):772-9. Epub 2006 Jun 1.

PMID:
16738684
12.

Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics.

Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, Alfieri AB, Cubeddu LX.

J Hum Hypertens. 2005 Mar;19(3):233-40.

PMID:
15565175
13.

CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity.

Ganapathipillai S, Laval G, Hoffmann IS, Castejon AM, Nicod J, Dick B, Frey FJ, Frey BM, Cubeddu LX, Ferrari P.

J Clin Endocrinol Metab. 2005 Feb;90(2):1220-5. Epub 2004 Oct 26.

PMID:
15507509
14.

Alpha-adducin polymorphism, salt sensitivity, nitric oxide excretion, and cardiovascular risk factors in normotensive Hispanics.

Castejon AM, Alfieri AB, Hoffmann IS, Rathinavelu A, Cubeddu LX.

Am J Hypertens. 2003 Dec;16(12):1018-24.

PMID:
14643575
15.

Ondansetron and metformin-induced gastrointestinal side effects.

Hoffmann IS, Roa M, Torrico F, Cubeddu LX.

Am J Ther. 2003 Nov-Dec;10(6):447-51.

PMID:
14624284
16.

Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population.

Cubeddu LX, Hoffmann IS, Aponte LM, Nuñez-Bogesits R, Medina-Suniaga H, Roa M, Garcia RS.

Am J Hypertens. 2003 May;16(5 Pt 1):343-9.

PMID:
12745194
17.

Lesion of caudate-putamen interneurons with kainic acid alters dopamine and serotonin metabolism in the olfactory tubercle of the rat.

Guevara BH, Torrico F, Hoffmann IS, Cubeddu LX.

Cell Mol Neurobiol. 2002 Dec;22(5-6):835-44.

PMID:
12585701
18.

Clustering of silent cardiovascular risk factors in apparently healthy Hispanics.

Hoffmann IS, Cubeddu LX.

J Hum Hypertens. 2002 Mar;16 Suppl 1:S137-41.

19.

Differential blood pressure effects of oral glucose and intravenous L-arginine in healthy lean normotensive and obese hypertensive subjects.

Castejon AM, Hoffmann IS, Jimenez E, Cubeddu RJ, Baldonedo RM, Cubeddu LX.

J Hum Hypertens. 2002 Mar;16 Suppl 1:S133-6.

20.

Insulin resistance and upper-normal glucose levels in hypertension: a review.

Cubeddu LX, Hoffmann IS.

J Hum Hypertens. 2002 Mar;16 Suppl 1:S52-5. Review.

22.

Nitric oxide and salt sensitivity.

Cubeddu LX, Alfieri AB, Hoffmann IS, Jimenez E, Roa CM, Cubeddu R, Palermo C, Baldonedo RM.

Am J Hypertens. 2000 Sep;13(9):973-9.

PMID:
10981546
23.

Insulin and blood pressure responses to changes in salt intake.

Cubeddu LX, Hoffmann IS, Jimenez E, Roa CM, Cubeddu RJ, Palermo C, Baldonedo RM.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S32-5.

24.

Ventral and dorsal striatal cholinergic neurons have different sensitivities to kainic acid.

Guevara BH, Hoffmann IS, Cubeddu LX.

Neurochem Int. 1997 Nov;31(5):723-30.

PMID:
9364458
25.

Differential effects of kainic acid on dopamine and serotonin metabolism in ventral and dorsal striatal regions.

Guevara BH, Hoffmann IS, Cubeddu LX.

Brain Res. 1997 Feb 21;749(1):139-42.

PMID:
9070639
26.

Comparative dopamine-acetylcholine interactions in the ventral and dorsal striatum of rabbit and rat brain.

Guevara BH, Talmaciu RK, Hoffmann IS, Cubeddu LX.

Brain Res. 1996 Sep 9;733(1):105-7.

PMID:
8891253
27.

Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors.

Hoffmann IS, Talmaciu RK, Aquino R, Cubeddu LX.

J Pharmacol Exp Ther. 1996 Aug;278(2):662-8.

PMID:
8768717
28.

Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.

Agneter E, Hoffmann IS, Singer EA, Cubeddu LX.

J Pharmacol Exp Ther. 1994 May;269(2):470-6.

PMID:
8182513
30.
31.

Carbachol-phorbol ester interactions at muscarinic receptors modulating dopamine release from rabbit striatal slices.

Cubeddu LX, Hoffmann IS, Talmaciu RK, Diliberto P, Lovemberg T.

Neurosci Lett. 1991 Oct 14;131(2):245-8.

PMID:
1762698
32.

Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL.

N Engl J Med. 1990 Mar 22;322(12):810-6.

34.
35.

Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.

Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX.

J Pharmacol Exp Ther. 1988 Jun;245(3):761-72.

PMID:
3385641
36.
37.

Dopamine autoreceptors modulate dopamine release from the prefrontal cortex.

Talmaciu RK, Hoffmann IS, Cubeddu LX.

J Neurochem. 1986 Sep;47(3):865-70.

PMID:
3734802
39.

Clonidine reduces elevated cerebrospinal fluid catecholamine levels in patients with essential hypertension.

Cubeddu LX, Hoffmann IS, Davila J, Barbella YR, Ordaz P.

Life Sci. 1984 Sep 24;35(13):1365-71.

PMID:
6482658
40.
41.
42.
43.
44.

Operational characteristics of the inhibitory feedback mechanism for regulation of dopamine release via presynaptic receptors.

Cubeddu LX, Hoffmann IS.

J Pharmacol Exp Ther. 1982 Nov;223(2):497-501. No abstract available.

PMID:
6290641
45.
46.

Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.

Hoffmann IS, Naylor RJ, Cubeddu LX.

J Pharmacol Exp Ther. 1980 Nov;215(2):486-93.

PMID:
7441511
47.

Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid.

Cubeddu LX, Hoffmann IS, Ferrari GB.

J Pharmacol Exp Ther. 1979 May;209(2):165-75. No abstract available.

PMID:
255152
48.

Effects of papaverine on the release and metabolism of dopamine in rat striatum.

Cubeddu L, Hoffmann IS, Paris VB.

J Pharmacol Exp Ther. 1979 Apr;209(1):73-8. No abstract available.

PMID:
85703

Supplemental Content

Loading ...
Support Center